Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Neurocrine Bioscience's CRF antagonists for stress-related disorders

Feb. 3, 1997

New CNS agents with 5-HT2C-antagonist activity from Fujisawa

Feb. 3, 1997

Teva generic approved

Jan. 31, 1997

CP-0840: Dual-action bradykinin antagonist/mu-opioid agonist from Cortech

Jan. 31, 1997

New MMP inhibitors reported by Warner-Lambert

Jan. 31, 1997

Potent NK1 antagonist reported by Servier

Jan. 30, 1997

Meperidine generic approved

Jan. 30, 1997

Candidate compound identified in Pharmacopeia/Berlex collaboration

Jan. 30, 1997

Clinical trials to begin on novel antidepressant from Korean company

Jan. 30, 1997

Schering Canada and University of Toronto collaborate on Alzheimer research

Jan. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...